Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 158.00 | |
5 mg | In stock | $ 390.00 | |
10 mg | In stock | $ 590.00 | |
25 mg | In stock | $ 943.00 | |
50 mg | In stock | $ 1,280.00 | |
100 mg | In stock | $ 1,730.00 | |
500 mg | In stock | $ 3,460.00 |
Description | Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion. |
In vivo | Spiroglumide (25、50、75、100 mg/kg; rat) dose-dependent inhibition of pentagastrin (16 µg/kg/h) induced acid hypersecretion.[1] |
Synonyms | CR-2194 |
Molecular Weight | 441.35 |
Formula | C21H26Cl2N2O4 |
CAS No. | 137795-35-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (113.29 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Spiroglumide 137795-35-8 GPCR/G Protein cholecystokinin CR2194 CR 2194 CR-2194 inhibitor inhibit